A new partnership between Walmart and drug maker Eli Lily will make it easier for people to access the super-popular weight loss drug Zepbound.

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

Walmart alone accounts for 24% of total SNAP spending, according to market research data firm Numerator (6). That means that if funding for the program lapses, the retail giant stands to lose an ...

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies ...

Walmart is pushing back against false viral rumors claiming it plans to close stores on Nov. 1 due to possible unrest over ...

Walmart will offer in‑store pickup of Eli Lilly’s discounted weight‑loss drug Zepbound, giving self‑pay customers easier, cheaper access nationwide.

Eli Lilly beat Q3 estimates with $7.02 EPS and $17.60 billion revenue, raising full-year guidance as Zepbound and Mounjaro ...

Eli Lilly stock (NYSE: LLY) is up 7% in a month, warranting investor attention following a key corporate development. Eli ...

November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or ...

Pharma giant Eli Lilly tapped Walmart to offer in-store pickups of Zepbound vials, marking the first retail collaboration for ...

Eli Lilly collaborates with Walmart to expand access to Zepbound via LillyDirect, offering DTC pricing and pharmacy pick-up ...

Eli Lilly said on Wednesday it is partnering with Walmart to sell its weight-loss treatment Zepbound at the retailer's ...